Metraipolis › archive › dc_611ddfebedef

Neoadjuvant camrelizumab in combination with chemotherapy followed by sequential radical surgery for locally advanced esophageal squamous cell carcinoma:… — Europe PMC PMID:42222400

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42222400
DOI: 10.3389/fonc.2026.1789575
License (as archived): solo-consultazione
Archived: 2026-11-01T16:36:22.852Z
SHA-256 of the archived text: c2b199591c0ce197f3bdefd6f7ecb9d292e6374dfa885c2853864662ba30eef5
Stable URL of this page: https://metraipolis.com/documento/dc_611ddfebedef

How to cite

Neoadjuvant camrelizumab in combination with chemotherapy followed by sequential radical surgery for locally advanced esophageal squamous cell carcinoma:… — Europe PMC PMID:42222400 — Europe PMC (en), https://europepmc.org/article/MED/42222400 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_611ddfebedef (Metraipolis archive dc_611ddfebedef, sha256 c2b199591c0ce197f3bdefd6f7ecb9d292e6374dfa885c2853864662ba30eef5)

BibTeX

@misc{dc611ddfebedef,
  title = {Neoadjuvant camrelizumab in combination with chemotherapy followed by sequential radical surgery for locally advanced esophageal squamous cell carcinoma:… — Europe PMC PMID:42222400},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42222400},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_611ddfebedef; sha256 c2b199591c0ce197f3bdefd6f7ecb9d292e6374dfa885c2853864662ba30eef5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222400. Agents can read the archived copy with the MCP tool read_document.